<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Beta cell deficiency underlies both type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and restoration or replacement of beta cell function is therefore the logical long-term solution to therapy </plain></SENT>
<SENT sid="1" pm="."><plain>This review sets out to describe the defects in beta cell mass and function in both forms of <z:mp ids='MP_0002055'>diabetes</z:mp>, summarises current understanding of the underlying causes of beta cell <z:hpo ids='HP_0011420'>death</z:hpo>, and the methodological limitations of determining beta cell mass in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>Finally, the potential effects of current and future treatment regimens on beta cell mass and turnover are considered </plain></SENT>
</text></document>